{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:10:31Z","timestamp":1780503031173,"version":"3.54.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cellsig.2025.111967","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:27:51Z","timestamp":1751376471000},"page":"111967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["PKM2: A novel helmsman of lipid metabolism"],"prefix":"10.1016","volume":"134","author":[{"given":"Zhijun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2025.111967_bb0005","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","article-title":"Lipid metabolism in cancer","volume":"279","author":"Santos","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.cellsig.2025.111967_bb0010","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2025.111967_bb0015","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"R\u00f6hrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2025.111967_bb0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCRESAHA.115.306398","article-title":"Surprises from genetic analyses of lipid risk factors for atherosclerosis","volume":"118","author":"Musunuru","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.cellsig.2025.111967_bb0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2019.02.015","article-title":"Genetics of common, complex coronary artery disease","volume":"177","author":"Musunuru","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2025.111967_bb0030","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.jmb.2019.09.016","article-title":"Recent insights into mechanisms of \u03b2-cell Lipo- and glucolipotoxicity in type 2 diabetes","volume":"432","author":"Lytrivi","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0035","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","article-title":"Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity","volume":"81","author":"Yoon","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2025.111967_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","journal-title":"Cancer Commun."},{"key":"10.1016\/j.cellsig.2025.111967_bb0045","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3389\/fimmu.2019.02993","article-title":"New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages","volume":"10","author":"Batista-Gonzalez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6314","article-title":"Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cellsig.2025.111967_bb0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4093\/dmj.2015.39.5.353","article-title":"Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia","volume":"39","author":"Parhofer","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.cellsig.2025.111967_bb0060","first-page":"1655","article-title":"Pyruvate kinase M2 at a glance","volume":"128","author":"Yang","year":"2015","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2025.111967_bb0065","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.15252\/embr.201643300","article-title":"PKM2, cancer metabolism, and the road ahead","volume":"17","author":"Dayton","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cellsig.2025.111967_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/242513","article-title":"PKM2, a central point of regulation in Cancer metabolism","volume":"2013","author":"Wong","year":"2013","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0075","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1074\/jbc.RA117.000100","article-title":"Pyruvate kinase M2 interacts with nuclear sterol regulatory element\u2013binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma","volume":"293","author":"Zhao","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2025.111967_bb0080","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108065","article-title":"PKM2-TMEM33 axis regulates lipid homeostasis in cancer cells by controlling SCAP stability","volume":"40","author":"Liu","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2025.111967_bb0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nmeth.2368","article-title":"Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells","volume":"10","author":"Hulce","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cellsig.2025.111967_bb0090","article-title":"Role of PKM2-mediated Immunometabolic reprogramming on development of cytokine storm","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nature06667","article-title":"Pyruvate kinase M2 is a phosphotyrosine-binding protein","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2025.111967_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molcel.2013.11.001","article-title":"PKM2 regulates chromosome segregation and mitosis progression of tumor cells","volume":"53","author":"Jiang","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2025.111967_bb0105","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/bies.201300084","article-title":"The Warburg effect then and now: from cancer to inflammatory diseases","volume":"35","author":"Palsson-McDermott","year":"2013","journal-title":"BioEssays"},{"key":"10.1016\/j.cellsig.2025.111967_bb0110","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2025.111967_bb0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.semcancer.2005.04.009","article-title":"Pyruvate kinase type M2 and its role in tumor growth and spreading","volume":"15","author":"Mazurek","year":"2005","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0120","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1021\/bi0474923","article-title":"Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis","volume":"44","author":"Dombrauckas","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.cellsig.2025.111967_bb0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2020.11.018","article-title":"Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics","volume":"503","author":"Zhu","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2025.111967_bb0130","first-page":"156","article-title":"The metabolism of leukocytes","volume":"5","author":"Karnovsky","year":"1968","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0135","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2025.111967_bb0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.20892\/j.issn.2095-3941.2018.0122","article-title":"PKM2 promotes reductive glutamine metabolism","volume":"15","author":"Miao","year":"2018","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.cellsig.2025.111967_bb0145","first-page":"27","article-title":"Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro","volume":"13","author":"Medes","year":"1953","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111967_bb0150","first-page":"358","article-title":"Increased lipogenesis in cancer cells: new players, novel targets","volume":"9","author":"Swinnen","year":"2006","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.cellsig.2025.111967_bb0155","article-title":"Role of PKM2-mediated Immunometabolic reprogramming on development of cytokine storm","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0160","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1074\/jbc.RA117.000100","article-title":"Pyruvate kinase M2 interacts with nuclear sterol regulatory element\u2013binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma","volume":"293","author":"Zhao","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2025.111967_bb0165","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0030-1267538","article-title":"The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis","volume":"30","author":"Sozio","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.cellsig.2025.111967_bb0170","series-title":"Current Prevention and Treatment Options for NAFLD","first-page":"149","author":"Wong","year":"2018"},{"key":"10.1016\/j.cellsig.2025.111967_bb0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The role and regulation of the peroxisome proliferator activated receptor alpha in human liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.cellsig.2025.111967_bb0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/MCB.15.1.351","article-title":"PPAR\u03b32 regulates adipose expression of the phosphoenolpyruvate Carboxykinase gene","volume":"15","author":"Tontonoz","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0185","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1002\/j.1460-2075.1996.tb00918.x","article-title":"PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene","volume":"15","author":"Schoonjans","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2025.111967_bb0190","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.cellsig.2025.111967_bb0195","doi-asserted-by":"crossref","first-page":"37603","DOI":"10.1074\/jbc.M604709200","article-title":"Aberrant hepatic expression of PPAR\u03b32 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis","volume":"281","author":"Zhang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2025.111967_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064258","article-title":"Peroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in mice","volume":"8","author":"Magliano","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.cellsig.2025.111967_bb0205","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-020-1528-x","article-title":"Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1\u03b1\/PPAR-\u03b3\/PKM2-mediated glycolysis","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111967_bb0210","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00018-023-04961-y","article-title":"Omentin-1 induces mechanically activated fibroblasts lipogenic differentiation through pkm2\/yap\/ppar\u03b3 pathway to promote lung fibrosis resolution","volume":"80","author":"Zhang","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellsig.2025.111967_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101634","article-title":"Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH","volume":"36","author":"Xu","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0220","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3748\/wjg.v27.i8.677","article-title":"G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment","volume":"27","author":"Yang","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn2977","article-title":"The role of G protein-coupled receptors in the pathology of Alzheimer\u2019s disease","volume":"12","author":"Thathiah","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cellsig.2025.111967_bb0230","doi-asserted-by":"crossref","first-page":"14953","DOI":"10.1038\/srep14953","article-title":"Mice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissue","volume":"5","author":"Godlewski","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2025.111967_bb0235","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/j.cell.2021.04.037","article-title":"Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis","volume":"184","author":"Johansen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2025.111967_bb0240","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41467-021-21066-x","article-title":"High-throughput phenotypic screen and transcriptional analysis identify new compounds and targets for macrophage reprogramming","volume":"12","author":"Hu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2025.111967_bb0245","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-024-45167-5","article-title":"Activation of GPR3-\u03b2-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis","volume":"15","author":"Dong","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2025.111967_bb0250","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.cellsig.2025.111967_bb0255","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cellsig.2025.111967_bb0260","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis\u2014new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0265","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2559.2006.02416.x","article-title":"Histological assessment of non-alcoholic fatty liver disease","volume":"49","author":"H\u00fcbscher","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.cellsig.2025.111967_bb0270","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cmet.2021.04.018","article-title":"PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease","volume":"33","author":"Moreno-Fernandez","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellsig.2025.111967_bb0275","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cmet.2018.01.007","article-title":"Digoxin suppresses pyruvate kinase M2-promoted HIF-1\u03b1 transactivation in steatohepatitis","volume":"27","author":"Ouyang","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellsig.2025.111967_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110380","article-title":"Lapachol treats non-alcoholic fatty liver disease by modulating the M1 polarization of Kupffer cells via PKM2","volume":"120","author":"Yang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0285","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.molcel.2012.01.001","article-title":"Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase","volume":"45","author":"Gao","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2025.111967_bb0290","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/15384047.2018.1564558","article-title":"Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway","volume":"20","author":"Ye","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cellsig.2025.111967_bb0295","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2020.05.009","article-title":"LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers","volume":"486","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2025.111967_bb0300","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cellsig.2018.01.021","article-title":"AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3\/NF-\u03baB axis","volume":"45","author":"Zheng","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2025.111967_bb0305","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14052","article-title":"BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect via the PI3K\/AKT signaling pathway","volume":"10","author":"Liu","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.cellsig.2025.111967_bb0310","doi-asserted-by":"crossref","first-page":"48155","DOI":"10.18632\/oncotarget.10179","article-title":"Il Yeom, AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2025.111967_bb0315","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.biopha.2018.06.009","article-title":"Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2","volume":"105","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2025.111967_bb0320","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in Cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cellsig.2025.111967_bb0325","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbrc.2015.02.112","article-title":"Secreted pyruvate kinase M2 facilitates cell migration via PI3K\/Akt and Wnt\/\u03b2-catenin pathway in colon cancer cells","volume":"459","author":"Yang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2025.111967_bb0330","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s41598-017-03031-1","article-title":"PKM2 promotes cell migration and inhibits autophagy by mediating PI3K\/AKT activation and contributes to the malignant development of gastric cancer","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2025.111967_bb0335","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/cbin.11950","article-title":"OTUB2 promotes the progression of endometrial cancer by regulating the PKM2-mediated PI3K\/AKT signaling pathway","volume":"47","author":"Zhang","year":"2023","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.cellsig.2025.111967_bb0340","doi-asserted-by":"crossref","first-page":"21524","DOI":"10.1038\/srep21524","article-title":"Pyruvate kinase M2 activates mTORC1 by phosphorylating AKT1S1","volume":"6","author":"He","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2025.111967_bb0345","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111967_bb0350","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cellsig.2025.111967_bb0355","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2025.111967_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2019.03.010","article-title":"Substrate channeling in the glycerol-3-phosphate pathway regulates the synthesis, storage and secretion of glycerolipids","volume":"1865","author":"Lee","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"10.1016\/j.cellsig.2025.111967_bb0365","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1038\/sj.onc.1208802","article-title":"PKB\/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP","volume":"24","author":"Porstmann","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2025.111967_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01788","article-title":"Role of the sterol regulatory element binding protein pathway in tumorigenesis","volume":"10","author":"Jiang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0375","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/onc.2015.179","article-title":"Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP","volume":"35","author":"Ricoult","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2025.111967_bb0380","doi-asserted-by":"crossref","first-page":"51999","DOI":"10.1074\/jbc.M405522200","article-title":"Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1\/SREBP1c","volume":"279","author":"Kim","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2025.111967_bb0385","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cmet.2019.07.012","article-title":"The MYC oncogene cooperates with sterol-regulated element-binding protein to regulate lipogenesis essential for neoplastic growth","volume":"30","author":"Gouw","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellsig.2025.111967_bb0390","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2174\/13816128113199990486","article-title":"Targeting SREBP-1-driven lipid metabolism to treat Cancer","volume":"20","author":"Guo","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cellsig.2025.111967_bb0395","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-\u03b1 prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2025.111967_bb0400","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","article-title":"ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent Warburg effect within the hypoxic tumor microenvironment","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2025.111967_bb0405","article-title":"Palmitic acid accelerates endothelial cell injury and cardiovascular dysfunction via Palmitoylation of PKM2","volume":"12","author":"He","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cellsig.2025.111967_bb0410","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1194\/jlr.RA119000382","article-title":"Role of pyruvate kinase M2 in oxidized LDL-induced macrophage foam cell formation and inflammation","volume":"61","author":"Kumar","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cellsig.2025.111967_bb0415","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2174\/13816128113199990486","article-title":"Targeting SREBP-1-driven lipid metabolism to treat Cancer","volume":"20","author":"Guo","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cellsig.2025.111967_bb0420","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108065","article-title":"PKM2-TMEM33 axis regulates lipid homeostasis in cancer cells by controlling SCAP stability","volume":"40","author":"Liu","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2025.111967_bb0425","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/onc.2011.137","article-title":"Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2025.111967_bb0430","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.canlet.2019.04.033","article-title":"Shikonin derivatives for cancer prevention and therapy","volume":"459","author":"Boulos","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2025.111967_bb0435","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/IJN.S401570","article-title":"Promising nanomedicines of Shikonin for Cancer therapy","volume":"18","author":"Yan","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.cellsig.2025.111967_bb0440","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13046-023-02688-z","article-title":"Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery","volume":"42","author":"Long","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111967_bb0445","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/onc.2011.137","article-title":"Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2025.111967_bb0450","first-page":"4017","article-title":"The PKM2 activator TEPP-46 attenuates MCD feeding-induced nonalcoholic steatohepatitis by inhibiting the activation of Kupffer cells","volume":"25","author":"Yang","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cellsig.2025.111967_bb0455","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/jdi.13478","article-title":"The PKM2 activator TEPP-46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF-1\u03b1 accumulation","volume":"12","author":"Liu","year":"2021","journal-title":"J. Diabetes Invest."},{"key":"10.1016\/j.cellsig.2025.111967_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114148","article-title":"TEPP-46 inhibits glycolysis to promote M2 polarization of microglia after ischemic stroke","volume":"149","author":"Xia","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0465","article-title":"Targeting pyruvate kinase M2 for the treatment of kidney disease","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0470","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aay9217","article-title":"Modulation of PKM activity affects the differentiation of T H 17 cells","volume":"13","author":"Seki","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.cellsig.2025.111967_bb0475","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.1002\/jcp.29549","article-title":"PKM2 regulates angiogenesis of VR-EPCs through modulating glycolysis, mitochondrial fission, and fusion","volume":"235","author":"Ren","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0480","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","article-title":"FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2","volume":"71","author":"Rao","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cellsig.2025.111967_bb0485","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrd837","article-title":"Nucleic-acid therapeutics: basic principles and recent applications","volume":"1","author":"Opalinska","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellsig.2025.111967_bb0490","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrd3459","article-title":"Targeting RNA to treat neuromuscular disease","volume":"10","author":"Muntoni","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellsig.2025.111967_bb0495","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1073\/pnas.0914845107","article-title":"The alternative splicing repressors hnRNP A1\/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism","volume":"107","author":"Clower","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2025.111967_bb0500","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature08697","article-title":"HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer","volume":"463","author":"David","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2025.111967_bb0505","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jmcb\/mjr030","article-title":"Exon-centric regulation of pyruvate kinase M alternative splicing via mutually exclusive exons","volume":"4","author":"Wang","year":"2012","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0510","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.120133","article-title":"Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides","volume":"2","author":"Wang","year":"2012","journal-title":"Open Biol."},{"key":"10.1016\/j.cellsig.2025.111967_bb0515","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/0008-5472.CAN-20-0948","article-title":"ASO-based PKM splice-switching therapy inhibits hepatocellular carcinoma growth","volume":"82","author":"Ma","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111967_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108345","article-title":"PKM splice-switching ASOs induce upregulation of dual-specificity phosphatases and dephosphorylation of ERK1\/2 in hepatocellular carcinoma","author":"Voss","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2025.111967_bb0525","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1111\/febs.13110","article-title":"Genome modification by <scp>CRISPR<\/scp> \/Cas9","volume":"281","author":"Ma","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.cellsig.2025.111967_bb0530","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/febs.16625","article-title":"Reciprocal abrogation of <scp>PKM<\/scp> isoforms: contradictory outcomes and differing impact of splicing signal on <scp>CRISPR<\/scp> \/Cas9 mediates gene editing in keratinocytes","volume":"290","author":"Nold","year":"2023","journal-title":"FEBS J."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825003821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825003821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:32:46Z","timestamp":1762317166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825003821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":106,"alternative-id":["S0898656825003821"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111967","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PKM2: A novel helmsman of lipid metabolism","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111967"}}